lovastatin has been researched along with Necrosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arruzazabala, L; Carbajal, D; Castaño, G; Gámez, R; Goicochea, E; Mas, R; Mendoza, N; Mendoza, S; Mesa, M; Noa, M | 1 |
Assie, N; Bruniquel, F; Degryse, AD; Delhon, A; Oms, P; van Haverbeke, G | 1 |
Chen, Z; Jia, Z; Moyana, T; Saxena, A; Warrington, R; Xiang, J | 1 |
Eydelloth, RS; Germershausen, JI; Grossman, SJ; MacDonald, JS; Schwartz, MS; Smith, PF; Stubbs, RJ | 1 |
Desager, JP; Harvengt, C; Horsmans, Y | 1 |
Alberts, AW; Bokelman, DL; Gerson, RJ; Kornbrust, DJ; MacDonald, JS; Majka, JA; Stubbs, RJ | 1 |
1 review(s) available for lovastatin and Necrosis
Article | Year |
---|---|
Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors.
Topics: Animals; Cataract; Dogs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Male; Necrosis; Rabbits; Rats; Simvastatin; Species Specificity; Stomach; Testis | 1989 |
5 other study(ies) available for lovastatin and Necrosis
Article | Year |
---|---|
Comparison of the cholesterol-lowering effects and toxicity of D-003 and lovastatin in normocholesterolaemic rabbits.
Topics: Administration, Oral; Animals; Anticholesteremic Agents; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Fatty Acids; Gallbladder; Kidney; Liver; Lovastatin; Male; Necrosis; Organ Size; Rabbits; Transaminases; Triglycerides | 2003 |
Biochemical changes and morphological alterations of liver and kidney in hamsters after administration of the HMG-coenzyme A reductase inhibitor, simvastatin: prevention and reversibility by mevalonate.
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Cricetinae; Dietary Fats; Eating; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Liver; Lovastatin; Male; Mevalonic Acid; Necrosis; Simvastatin | 1995 |
Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cancer Vaccines; Cell Differentiation; Cell Movement; Dendritic Cells; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Interleukin-4; Lovastatin; Lung Neoplasms; Lymphocyte Activation; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Necrosis; Phagocytosis; Receptors, CCR7; Receptors, Chemokine; T-Lymphocytes; TRPC Cation Channels; Tumor Cells, Cultured | 2001 |
Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cyclosporin A: evaluation in a rat model.
Topics: Animals; Anticholesteremic Agents; Cyclosporine; Drug Synergism; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Muscles; Muscular Diseases; Necrosis; Pravastatin; Rats; Rats, Inbred Strains; Simvastatin; Structure-Activity Relationship | 1992 |
Biochemical changes and morphological alterations of the liver in guinea-pigs after administration of simvastatin (HMG CoA reductase-inhibitor).
Topics: Aminopyrine N-Demethylase; Animals; Bile Ducts; Body Weight; Cholesterol; Colestipol; Cytochrome P-450 Enzyme System; Eating; Guinea Pigs; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Male; Necrosis; Simvastatin | 1990 |